Cinnamaldehyde for the Treatment of Microbial Infections: Evidence Obtained from Experimental Models

Curr Med Chem. 2023;30(31):3506-3526. doi: 10.2174/0929867329666221005105108.

Abstract

Cinnamaldehyde (CNM) is a cyclic terpene alcohol found as the major compound of essential oils from some plants of the genus Cinnamomum (Lauraceae). CNM has several reported pharmacological activities, including antimicrobial, antivirulence, antioxidant, and immunomodulatory effects. These properties make CNM an attractive lead molecule for the development of anti-infective agents. In this descriptive review, we discuss the application of CNM in experimental models of microbial infection using invertebrate and vertebrate organisms. CNM (pure or in formulations) has been successfully applied in the treatment of infections caused by a range of bacterial (such as Cronobacter sakazakii, Escherichia coli, Listeria monocytogenes, Mycobacterium tuberculosis, Pseudomonas aeruginosa, Salmonella enterica, Staphylococcus aureus, Streptococcus agalactiae, Vibrio cholerae) and fungal (such as Aspergillus fumigatus, Candida albicans and Cryptococcus neoformans) pathogens. All these experimental evidence-based findings have promoted the use of cinnamaldehyde as the leading molecule for developing new anti- infective drugs.

Keywords: Cinnamomum sp.; anti-infective agents; essential oils; experimental models; immunomodulation; virulence factors.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Anti-Infective Agents* / pharmacology
  • Escherichia coli
  • Humans
  • Microbial Sensitivity Tests
  • Models, Theoretical
  • Oils, Volatile*
  • Terpenes / pharmacology

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • cinnamaldehyde
  • Oils, Volatile
  • Terpenes